SMN-C3: A Potent SMN2 Splicing Modulator for Spinal Muscular Atrophy Research
Discover the breakthrough potential of SMN-C3 in treating spinal muscular atrophy through advanced SMN2 splicing modulation.
Get a Quote & SampleProduct Core Value
SMN-C3
SMN-C3 is a highly selective, orally available small molecule designed to enhance the production of full-length SMN2 messenger RNA. This targeted approach aims to significantly increase SMN protein levels, which is crucial for treating conditions like spinal muscular atrophy (SMA).
- Increase SMN protein levels SMN-C3: This compound is engineered to boost SMN protein, a critical factor in combating neurodegenerative diseases.
- Improve motor function SMA treatment: Early research suggests SMN-C3 can lead to significant improvements in motor function for individuals with SMA.
- SMN-C3 phase I clinical trials: The compound is currently undergoing Phase I clinical trials, indicating progress towards therapeutic application.
- Small molecule SMN2 modulator: As a sophisticated small molecule, it offers a precise method for modulating SMN2 gene expression.
Key Advantages
Enhanced Efficacy
The selective SMN2 splicing modulation by SMN-C3 offers a targeted therapeutic strategy, a vital aspect for effective spinal muscular atrophy treatment.
Promising Preclinical Results
Studies demonstrate SMN-C3's ability to protect the neuromuscular circuit and improve motor function, showcasing its therapeutic potential in animal models.
Oral Bioavailability
Being orally active, SMN-C3 provides a convenient and patient-friendly administration route, differentiating it from other treatment modalities in drug development.
Key Applications
Neuromuscular Disease Research
Investigate SMN-C3's role in understanding and treating neuromuscular disorders, contributing to advancements in biomedical research.
Pharmaceutical Development
Utilize SMN-C3 as a key component in the development of novel therapies for genetic disorders, supporting therapeutic development.
Genetic Therapy Innovations
Explore SMN-C3 as a tool to modulate gene expression, fostering innovation in genetic disorder treatments.
Biotechnology Advancements
Leverage SMN-C3's unique mechanism for pioneering new treatments in the field of biotechnology, particularly for rare diseases.